Overexpression of p73 as a tissue marker for high-risk gastritis

Clinical Cancer Research

Volumn 16, Issue 12, 2010, Pages 3253-3259

  Carrasco, Gonzalo ^a,d   Diaz, Jose ^a   Valbuena, Jose R ^a   Ibanez, Paulina ^a   Rodriguez, Paz ^a   Araya, Gabriela ^a   Rodriguez, Carolina ^a   Torres, Javiera ^a   Duarte, Ignacio ^a   Aravena, Edmundo ^b   Mena, Fernando ^c   Barrientos, Carlos ^b,e   Corvalan, Alejandro H ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL SAN BORJA ARRIARÁN   (Chile)

^c Hospital Max Peralta   (Costa Rica)

^d Hospital Parroquial de San Bernardo   (Chile)

^e Centro Oncológico Fundación Arturo López Pérez   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR RECEPTOR; FRAGILE HISTIDINE TRIAD PROTEIN; HEAT SHOCK PROTEIN 90; PROTEIN P53; PROTEIN P73; STAT1 PROTEIN;

ARTICLE; ATROPHY; CELL INFILTRATION; CHRONIC GASTRITIS; CHRONIC INFLAMMATION; CLUSTER ANALYSIS; CONTINGENCY TABLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GASTRITIS; GENE OVEREXPRESSION; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINE METAPLASIA; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH CANCER; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; ATROPHY; BIOLOGICAL MARKERS; CHRONIC DISEASE; DNA-BINDING PROTEINS; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MIDDLE AGED; NUCLEAR PROTEINS; PRECANCEROUS CONDITIONS; RISK FACTORS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 77953721353     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-2491     Document Type: Article

References (41)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Parkin DM. International variation. Oncogene 2004;23:6329-40.
3. Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008;103:510-4.
4. Bernal C, Aguayo F, Villarroel C, et al. Reprimo as a potential biomarker for early detection in gastric cancer. Clin Cancer Res 2008;14:6264-9.
5. Rugge M, Correa P, Dixon MF, et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000;24:167-76. (Pubitemid 30078704)
6. Vieth M, Stolte M. Elevated risk for gastric adenocarcinoma can be predicted from histomorphology. World J Gastroenterol 2006;12:6109-14. (Pubitemid 44688158)
7. Tan YK, Fielding JW. Early diagnosis of early gastric cancer. Eur J Gastroenterol Hepatol 2006;18:821-9.
8. Li M, Liu L, Wang Z, et al. Overexpression of hMSH2 and hMLH1 protein in certain gastric cancers and their surrounding mucosae. Oncol Rep 2008;19:401-6. (Pubitemid 351176100)
9. Cancer JRSoG. Japanese classification of gastric carcinoma. 1st English ed Tokyo: Kanehara; 1995.
10. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
11. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. APMIS 1965;64:31-49.
12. Rugge M, Kim JG, Mahachai V, et al. OLGA gastritis staging in young adults and country-specific gastric cancer risk. Int J Surg Pathol 2008;16:150-4. (Pubitemid 351549765)
13. Rugge M, Correa P, Di Mario F, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008;40:650-8.
14. Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007;56:631-6. (Pubitemid 46662927)
15. Bernal C, Vargas M, Ossandon F, et al. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis. Biol Res 2008;41:303-15.
16. Ernst M, Najdovska M, Grail D, et al. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 2008;118:1727-38. (Pubitemid 351632376)
17. Wei J, O'Brien D, Vilgelm A, et al. Interaction of Helicobacter pylori with gastric epithelial cells is mediated by the p53 protein family. Gastroenterology 2008;134:1412-23. (Pubitemid 351615353)
18. Zavala GL, Luengo JV, Ossandon CF, et al. [Hierarchical clustering analysis to detect associations between clinical and pathological features of gastric tumors and hypermethylation of suppressor genes]. Rev Med Chil 2007;135:17-25.
19. Pekarsky Y, Zanesi N, Palamarchuk A, Huebner K, Croce CM. FHIT: from gene discovery to cancer treatment and prevention. Lancet Oncol 2002;3:748-54. (Pubitemid 35446744)
20. Zhao P, Liu W, Lu YL. Clinicopathological significance of FHIT protein expression in gastric adenocarcinoma patients. World J Gastroenterol 2005;11:5735-8. (Pubitemid 41662847)
21. Kishimoto I, Mitomi H, Ohkura Y, Kanazawa H, Fukui N, Watanabe M. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas. J Surg Oncol 2008;98:60-6. (Pubitemid 351976956)
22. Lang SA, Klein D, Moser C, et al. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo. Mol Cancer Ther 2007;6:1123-32. (Pubitemid 46554583)
23. Lieto E, Ferraraccio F, Orditura M, et al. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. Ann Surg Oncol 2008;15:69-79.
24. Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P. New aspects of Helicobacter pylori infection involvement in gastric oncogenesis. J Surg Res 2008;146:149-58. (Pubitemid 351442939)
25. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21. (Pubitemid 32397092)
26. Nick TG, Campbell KM. Logistic regression. Methods Mol Biol 2007; 404:273-301.
27. Makretsov NA, Huntsman DG, Nielsen TO, et al. Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma. Clin Cancer Res 2004;10:6143-51.
28. Camp RL, Neumeister V, Rimm DL. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. J Clin Oncol 2008;26:5630-7.
29. Park ES, Do IG, Park CK, et al. Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection. Clin Cancer Res 2009;15:291-8.
30. Saeed AI, Sharov V, White J, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003; 34:374-8. (Pubitemid 36184095)
31. Saeed AI, Bhagabati NK, Braisted JC, et al. TM4 microarray software suite. Methods Enzymol 2006;411:134-93.
32. Dudoit S, Gentleman RC, Quackenbush J. Open source software for the analysis of microarray data. Biotechniques 2003;Suppl:45-51. (Pubitemid 36298158)
33. Kang MJ, Park BJ, Byun DS, et al. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma. Clin Cancer Res 2000;6:1767-71.
34. Tomkova K, Belkhiri A, El-Rifai W, Zaika AI. p73 isoforms can induce T-cell factor-dependent transcription in gastrointestinal cells. Cancer Res 2004;64:6390-3.
35. Kim SH, Lee SH, Choi YL, Wang LH, Park CK, Shin YK. Extensive alteration in the expression profiles of TGFB pathway signaling components and TP53 is observed along the gastric dysplasia-carcinoma sequence. Histol Histopathol 2008;23:1439-52.
36. Pinto-de-Sousa J, Silva F, David L, et al. Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma. Histopathology 2004;44:323-31.
37. Ossandon FJ, Villarroel C, Aguayo F, et al. In silico analysis of gastric carcinoma Serial Analysis of Gene Expression libraries reveals different profiles associated with ethnicity. Mol Cancer 2008;7:22.
38. Pass HI, Liu Z, Wali A, et al. Gene expression profiles predict survival and progression of pleural mesothelioma. Clin Cancer Res 2004;10:849-59.
39. Dietel M, Schafer R. Systems pathology-or how to solve the complex problem of predictive pathology. Virchows Arch 2008; 453:309-12.
40. Donovan MJ, Costa J, Cordon-Cardo C. Systems pathology: a paradigm shift in the practice of diagnostic and predictive pathology. Cancer 2009;115:3078-84.
41. Faratian D, Clyde RG, Crawford JW, Harrison DJ. Systems pathology-taking molecular pathology into a new dimension. Nat Rev Clin Oncol 2009.